Axcella Health Inc. (NASDAQ: AXLA) stock fell -38.23% on Friday to $0.62 against a previous-day closing price of $1.01. With 20.55 million shares changed hands, the volume of the stock remained heavier than its average volume of 19.65 million shares. The 52-week range on AXLA shows that it touched its highest point at $2.49 and its lowest point at $0.10 during that stretch. It currently has a 1-year price target of $5.64. Beta for the stock currently stands at 1.02.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AXLA was down-trending over the past week, with a drop of -36.34%, but this was up by 291.65% over a month. Three-month performance surged to 99.33% while six-month performance rose 25.28%. The stock lost -62.64% in the past year, while it has gained 90.50% so far this year. A look at the trailing 12-month EPS for AXLA yields -0.77 with Next year EPS estimates of -0.20. For the next quarter, that number is -0.05. This implies an EPS growth rate of 11.90% for this year and 0.00% for next year.
Float and Shares Shorts:
At present, 73.69 million AXLA shares are outstanding with a float of 55.86 million shares on hand for trading. On Aug 30, 2023, short shares totaled 9.91 million, which was 13.45% higher than short shares on Jul 30, 2023. In addition to Mr. William R. Hinshaw Jr. as the firm’s Pres, CEO & Director, Dr. Paul Fehlner J.D., Ph.D. serves as its Sr. VP, Chief Legal Officer & Corp. Sec..
Through their ownership of 66.68% of AXLA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 9.20% of AXLA, in contrast to 38.62% held by mutual funds. Shares owned by individuals account for -2.18%. As the largest shareholder in AXLA with 4.01% of the stake, Fidelity Management & Research Co holds 2,955,724 shares worth 2,955,724. A second-largest stockholder of AXLA, The Vanguard Group, Inc., holds 815,002 shares, controlling over 1.11% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in AXLA, holding 338,313 shares or 0.46% stake. With a 3.77% stake in AXLA, the Fidelity Growth Company Fund is the largest stakeholder. A total of 2,775,933 shares are owned by the mutual fund manager. The Fidelity Select Port. – Biotechno, which owns about 2.25% of AXLA stock, is the second-largest Mutual Fund holder. It holds 1,661,354 shares valued at 0.38 million. Fidelity Series Growth Company Fu holds 1.18% of the stake in AXLA, owning 871,560 shares worth 0.2 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, AXLA reported revenue of $0.00 and operating income of -$20.62M. The EBITDA in the recently reported quarter was -$20.62M and diluted EPS was -$0.40.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AXLA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AXLA analysts setting a high price target of $1.50 and a low target of $1.50, the average target price over the next 12 months is $1.50. Based on these targets, AXLA could surge 141.94% to reach the target high and rise by 141.94% to reach the target low. Reaching the average price target will result in a growth of 141.94% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded AXLA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 8 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 14,097,517 while 16,679 shares were sold.